440 related articles for article (PubMed ID: 17851934)
1. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment.
Van Wijck F; Staecker H; Lefebvre PP
Acta Otolaryngol; 2007 Oct; 127(10):1012-7. PubMed ID: 17851934
[TBL] [Abstract][Full Text] [Related]
2. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.
Xenellis J; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Segas J; Tzagaroulakis A; Ferekidis E
Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534
[TBL] [Abstract][Full Text] [Related]
3. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
4. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
Plaza G; Herráiz C
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
[TBL] [Abstract][Full Text] [Related]
5. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study.
Lefebvre PP; Staecker H
Acta Otolaryngol; 2002 Oct; 122(7):698-702. PubMed ID: 12484644
[TBL] [Abstract][Full Text] [Related]
6. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.
Van Wijk F; Staecker H; Keithley E; Lefebvre PP
Audiol Neurootol; 2006; 11(6):357-65. PubMed ID: 16988499
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
[TBL] [Abstract][Full Text] [Related]
8. Hearing evaluation of intratympanic methylprednisolone perfusion for refractory sudden sensorineural hearing loss.
She W; Dai Y; Du X; Yu C; Chen F; Wang J; Qin X
Otolaryngol Head Neck Surg; 2010 Feb; 142(2):266-71. PubMed ID: 20115986
[TBL] [Abstract][Full Text] [Related]
9. Intratympanic steroid therapy using the Silverstein Microwick™ for refractory sudden sensorineural hearing loss increases speech intelligibility.
Barriat S; van Wijck F; Staecker H; Lefebvre PP
Audiol Neurootol; 2012; 17(2):105-11. PubMed ID: 21860229
[TBL] [Abstract][Full Text] [Related]
10. Transtympanic steroids for treatment of sudden hearing loss.
Gianoli GJ; Li JC
Otolaryngol Head Neck Surg; 2001 Sep; 125(3):142-6. PubMed ID: 11555744
[TBL] [Abstract][Full Text] [Related]
11. Therapy of idiopathic sudden sensorineural hearing loss with intratympanic steroid injection.
Khaimook W; Jantarapattana K
J Med Assoc Thai; 2011 Dec; 94(12):1495-9. PubMed ID: 22295738
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic intratympanic methylprednisolone injection for treatment of refractory sudden sensorineural hearing loss and one case in pregnancy.
Chen Y; Wen L; Hu P; Qiu J; Lu L; Qiao L
J Otolaryngol Head Neck Surg; 2010 Dec; 39(6):640-5. PubMed ID: 21144358
[TBL] [Abstract][Full Text] [Related]
13. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss.
Arslan N; Oğuz H; Demirci M; Şafak MA; İslam A; Kaytez SK; Samim E
Otol Neurotol; 2011 Apr; 32(3):393-7. PubMed ID: 21221047
[TBL] [Abstract][Full Text] [Related]
14. Intratympanic methylprednisolone for sudden sensorineural hearing loss.
Kiliç R; Safak MA; Oğuz H; Kargin S; Demirci M; Samim E; Ozlüoğlu LN
Otol Neurotol; 2007 Apr; 28(3):312-6. PubMed ID: 17414035
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss.
Chou YF; Chen PR; Kuo IJ; Yu SH; Wen YH; Wu HP
Laryngoscope; 2013 Sep; 123(9):2264-9. PubMed ID: 23804460
[TBL] [Abstract][Full Text] [Related]
16. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.
Wu HP; Chou YF; Yu SH; Wang CP; Hsu CJ; Chen PR
Otol Neurotol; 2011 Jul; 32(5):774-9. PubMed ID: 21646929
[TBL] [Abstract][Full Text] [Related]
17. Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study.
Li P; Zeng XL; Ye J; Yang QT; Zhang GH; Li Y
Audiol Neurootol; 2011; 16(3):198-202. PubMed ID: 20948195
[TBL] [Abstract][Full Text] [Related]
18. Intratympanic methylprednisolone in refractory sudden hearing loss: a 27-patient case series with univariate and multivariate analysis.
Dallan I; De Vito A; Fattori B; Casani AP; Panicucci E; Berrettini S; Marchetti M; Nacci A
Otol Neurotol; 2010 Jan; 31(1):25-30. PubMed ID: 19940792
[TBL] [Abstract][Full Text] [Related]
19. Transtympanic steroids as a salvage therapy in sudden hearing loss: preliminary results.
Dallan I; Bruschini L; Nacci A; Bruschini P; Traino C; Rognini F; Fattori B
ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):247-52. PubMed ID: 16679810
[TBL] [Abstract][Full Text] [Related]
20. Intratympanic steroid therapy for refractory sudden sensory hearing loss: a 12-year experience with the Silverstein catheter.
Vanwijck F; Rogister F; Pierre Barriat S; Camby S; Lefebvre P
Acta Otolaryngol; 2019 Feb; 139(2):111-116. PubMed ID: 30794063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
